Methsuximide
Celontin
Anti-epileptic Agent
NADAC/unit
N/A
No Shortage
Tier 1: 20.1%
PA Req: 0.3%
1 Manufacturers
1 ANDAs
Methsuximide prevents seizures by stabilizing electrical activity in the brain.
Generic Manufacturers
NOVITIUM PHARMA LLCPARKE DAVIS DIV WARNER LAMBERT CO
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
